ASBP
Aspire Biopharma
ASBP
ASBP
61 hedge funds and large institutions have $260M invested in Aspire Biopharma in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.8M | |
| 2 | +$4.59M | |
| 3 | +$4.04M | |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$2.54M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.31M |
Top Sellers
| 1 | -$4.59M | |
| 2 | -$3.7M | |
| 3 | -$2.99M | |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.54M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.02M |